This company has been marked as potentially delisted and may not be actively trading. Nevro (NVRO) News Today Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsEarningsFDA EventsHeadlinesInsider TradesOwnershipShort InterestTrendsBuy This Stock NVRO Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period DATA BREACH ALERT: Edelson Lechtzin LLP Is Investigating Claims On Behalf Of Nevro Corp. Customers Whose Data May Have Been CompromisedApril 10, 2025 | globenewswire.comPrudential Financial Inc. Boosts Holdings in Nevro Corp. (NYSE:NVRO)April 10, 2025 | marketbeat.comNevro (NYSE:NVRO) Coverage Initiated at StockNews.comApril 8, 2025 | marketbeat.comNevro Corp. Investigated by Federman & Sherwood for Data BreachApril 3, 2025 | globenewswire.comGlobus Medical Completes Acquisition of Nevro Corp.April 3, 2025 | tipranks.comNevro Corp Completes Merger and Delists from NYSEApril 3, 2025 | tipranks.comGlobus Medical Inc (GMED) Completes Acquisition of Nevro Corp, Expanding Market OpportunitiesApril 3, 2025 | gurufocus.comStockNews.com Begins Coverage on Nevro (NYSE:NVRO)March 30, 2025 | marketbeat.comNevro Corp. (NYSE:NVRO) Given Average Rating of "Reduce" by AnalystsMarch 28, 2025 | marketbeat.comAnalysts Have Conflicting Sentiments on These Healthcare Companies: Nevro Corp (NVRO), Globus Medical (GMED) and Vertex Pharmaceuticals (VRTX)March 25, 2025 | markets.businessinsider.comNevro (NYSE:NVRO) Coverage Initiated by Analysts at StockNews.comMarch 22, 2025 | marketbeat.comStockNews.com Initiates Coverage on Nevro (NYSE:NVRO)March 14, 2025 | marketbeat.comNevro (NYSE:NVRO) Earns Hold Rating from Analysts at StockNews.comMarch 6, 2025 | marketbeat.comAnalysts Offer Insights on Healthcare Companies: Alpha Teknova (TKNO), Wave Life Sciences (WVE) and Nevro Corp (NVRO)March 5, 2025 | markets.businessinsider.comNevro is not issuing FY25 guidanceMarch 5, 2025 | markets.businessinsider.comNevro (NYSE:NVRO) Issues Earnings Results, Beats Estimates By $0.15 EPSMarch 5, 2025 | marketbeat.comNevro Corp.: Nevro Reports Fourth-Quarter and Full-Year 2024 Financial ResultsMarch 5, 2025 | finanznachrichten.deNevro Reports Fourth-Quarter and Full-Year 2024 Financial ResultsMarch 4, 2025 | prnewswire.comNevro Corp. (NYSE:NVRO) Short Interest UpdateMarch 3, 2025 | marketbeat.comNevro Corp. (NYSE:NVRO) Given Consensus Rating of "Reduce" by BrokeragesMarch 3, 2025 | marketbeat.comNevro (NYSE:NVRO) Now Covered by Analysts at StockNews.comFebruary 26, 2025 | marketbeat.comShareholder Alert: The Ademi Firm investigates whether Nevro Corp. ...February 24, 2025 | gurufocus.comShareholder Alert: The Ademi Firm investigates whether Nevro Corp. is obtaining a Fair Price for its Public ShareholdersFebruary 24, 2025 | prnewswire.comAnalysts Offer Insights on Healthcare Companies: Globus Medical (GMED) and Nevro Corp (NVRO)February 24, 2025 | markets.businessinsider.comGlobus Medical price target lowered to $93 from $95 at Wells FargoFebruary 21, 2025 | markets.businessinsider.comGlobus Medical's SWOT analysis: stock outlook amid acquisition and FDA warningFebruary 17, 2025 | msn.comNevro Corp's SWOT analysis: acquisition shakes up struggling SCS stockFebruary 17, 2025 | msn.comARMISTICE CAPITAL, LLC Increases Stake in Nevro CorpFebruary 15, 2025 | gurufocus.comShay Capital LLC Reduces Stake in Nevro Corp: An In-Depth AnalysisFebruary 14, 2025 | gurufocus.comEngaged Capital's Q4 moves include BlackLine, Nevro exits, new stake in Chart IndustriesFebruary 14, 2025 | seekingalpha.comNevro (NVRO) to Release Earnings on WednesdayFebruary 12, 2025 | marketbeat.comJefferies raises Nevro stock rating, boosts price target to $5.85February 10, 2025 | msn.comNevro (NYSE:NVRO) Stock Rating Upgraded by Jefferies Financial GroupFebruary 10, 2025 | marketbeat.comNevro upgraded to Hold from Underperform at JefferiesFebruary 8, 2025 | markets.businessinsider.comPiper Sandler Upgrades Nevro (NVRO)February 8, 2025 | msn.comCanaccord Genuity Group Issues Positive Forecast for Nevro (NYSE:NVRO) Stock PriceFebruary 7, 2025 | marketbeat.comNevro price target raised to $5.85 from $4 at CanaccordFebruary 7, 2025 | markets.businessinsider.comNevro (NYSE:NVRO) Upgraded at Piper SandlerFebruary 7, 2025 | marketbeat.comPiper Sandler raises Nevro stock to Neutral, cuts target to $5.85February 7, 2025 | msn.comNevro upgraded to Neutral from Underweight at Piper SandlerFebruary 6, 2025 | markets.businessinsider.comGlobus Medical To Acquire Nevro For $250 MlnFebruary 6, 2025 | markets.businessinsider.comGlobus Medical to Acquire Nevro Corp. to Expand Treatment Options for PatientsFebruary 6, 2025 | finance.yahoo.comGlobus acquisition of Nevro ‘fairly low-risk bet,’ says BTIGFebruary 6, 2025 | markets.businessinsider.comGlobus Medical to acquire Nevro for $5.85 per shareFebruary 6, 2025 | msn.comGlobus Medical Announces Acquisition of Nevro CorpFebruary 6, 2025 | tipranks.comSHAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Nevro Corp. - NVROFebruary 6, 2025 | prnewswire.comNVRO Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Nevro Corp. Is Fair to ShareholdersFebruary 6, 2025 | businesswire.comGlobus Medical to Acquire Nevro Corp. in All-Cash Transaction Valued at $250 MillionFebruary 6, 2025 | quiverquant.comQShareholder Alert: Ademi & Fruchter LLP Investigates Whether Nevro Corp. Is Obtaining a Fair Price for Its Public ShareholdersFebruary 6, 2025 | businesswire.comNevro Corp. (NYSE:NVRO) Receives Consensus Rating of "Reduce" from BrokeragesFebruary 6, 2025 | marketbeat.com Get Nevro News Delivered to You Automatically Sign up to receive the latest news and ratings for NVRO and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. NVRO Media Mentions By Week NVRO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NVRO News Sentiment▼0.000.93▲Average Medical News Sentiment NVRO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NVRO Articles This Week▼04▲NVRO Articles Average Week Get the Latest News and Ratings for NVRO and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Nevro and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Beta Bionics News Today Embecta News Today Kestra Medical Technologies News Today Tandem Diabetes Care News Today AxoGen News Today SiBone News Today Bioventus News Today AVANOS MEDICAL News Today ZimVie News Today OrthoPediatrics News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:NVRO) was last updated on 9/13/2025 by MarketBeat.com Staff From Our PartnersWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredOctober 16 Changes the Microchip Game — and InvestingWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nevro Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nevro With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NVRO Stock Alerts